TNF and psoriasis: This study seeks to determine whether biologic therapies influence the development and prevalence of SKs in psoriasis patients and whether different biologic agents (TNF-α inhibitors, IL-17 inhibitors, and IL-23 inhibitors) have distinct effects on SK occurrence.